MX2025003929A - Composiciones y métodos para la modulación de la actividad de macrófagos - Google Patents

Composiciones y métodos para la modulación de la actividad de macrófagos

Info

Publication number
MX2025003929A
MX2025003929A MX2025003929A MX2025003929A MX2025003929A MX 2025003929 A MX2025003929 A MX 2025003929A MX 2025003929 A MX2025003929 A MX 2025003929A MX 2025003929 A MX2025003929 A MX 2025003929A MX 2025003929 A MX2025003929 A MX 2025003929A
Authority
MX
Mexico
Prior art keywords
modulation
compositions
methods
macrophage activity
human
Prior art date
Application number
MX2025003929A
Other languages
English (en)
Spanish (es)
Inventor
Luca Cassetta
Stephen Myatt
Carola Ries
Krzysztof B Wicher
Original Assignee
Macomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2023/050592 external-priority patent/WO2023170434A1/en
Application filed by Macomics Ltd filed Critical Macomics Ltd
Publication of MX2025003929A publication Critical patent/MX2025003929A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2025003929A 2022-10-04 2025-04-02 Composiciones y métodos para la modulación de la actividad de macrófagos MX2025003929A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2214614.6A GB202214614D0 (en) 2022-10-04 2022-10-04 Compositions and methods for modulation of macrophage
PCT/GB2023/050592 WO2023170434A1 (en) 2022-03-11 2023-03-13 Compositions and methods for modulation of macrophage activity

Publications (1)

Publication Number Publication Date
MX2025003929A true MX2025003929A (es) 2025-05-02

Family

ID=84000149

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2025003929A MX2025003929A (es) 2022-10-04 2025-04-02 Composiciones y métodos para la modulación de la actividad de macrófagos

Country Status (8)

Country Link
JP (1) JP2025535192A (cg-RX-API-DMAC10.html)
KR (1) KR20250096720A (cg-RX-API-DMAC10.html)
CN (1) CN120435496A (cg-RX-API-DMAC10.html)
AU (1) AU2023232991A1 (cg-RX-API-DMAC10.html)
CR (1) CR20250172A (cg-RX-API-DMAC10.html)
GB (1) GB202214614D0 (cg-RX-API-DMAC10.html)
IL (1) IL319958A (cg-RX-API-DMAC10.html)
MX (1) MX2025003929A (cg-RX-API-DMAC10.html)

Also Published As

Publication number Publication date
IL319958A (en) 2025-05-01
JP2025535192A (ja) 2025-10-22
GB202214614D0 (en) 2022-11-16
KR20250096720A (ko) 2025-06-27
CN120435496A (zh) 2025-08-05
AU2023232991A1 (en) 2025-04-10
CR20250172A (es) 2025-09-04

Similar Documents

Publication Publication Date Title
DOP2024000220A (es) Anticuerpos il-11
DK202300015Y9 (da) Ikke-animalsk baserede proteinkilder med funktionelle egenskaber
DOP2020000236A (es) Anticuerpos il-1 1ra
CY1123555T1 (el) Συμπλοκο πρωτεϊνης ιντερλευκινης 15 και χρηση αυτου
JOP20200343A1 (ar) بروتين ربط مولد ضد مضاد لـ steap1
UA130422C2 (uk) Варіант та ізоформа антитіла зі зниженою біологічною активністю
MX2019009346A (es) Variantes de polipeptidos y usos de los mismos.
WO2020069330A3 (en) Inhibitors of vap-1
EA201791773A1 (ru) Цистеиновая протеаза
CL2021000232S1 (es) Parte de afeitadora.
MX2023014154A (es) Anticuerpos anti-ccr8.
WO2021203016A3 (en) Protein-protein interaction stabilizers
WO2019126641A3 (en) Modulation of frataxin expression
MX2021010665A (es) Metodos de tratamiento de amiloidosis al.
EP3581126A4 (en) FORWARD EXTRUSION, CUT, HEMOSTASE AND HEALING SET USING ULTRASONIC WAVE
AR115798A1 (es) Catalizadores para la deshidrogenación oxidativa de alcanos
PH12020551985A1 (en) Anti-human tlr7 antibody
CR20250172A (es) Composiciones y métodos para la modulación de la actividad de macrófagos
ZA202300222B (en) Anti-αlpha-4-βeta-7 antibodies
MX2023011919A (es) Construcciones de proteinas de union a antigenos y anticuerpos y usos de estos.
BR112022003978A2 (pt) Método e dispositivo de processamento.
WO2020046769A8 (en) Hematostick/hematodart
JP1735812S (ja) 化粧品用ボトル
CL2023002749S1 (es) Dispositivo de electroporación.
JP1717162S (ja) 脱毛器